Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210415050983N5Phase 3Completed
Phase 3, randomised trial in lumbar disc disease comparing Bupivacaine ESP block with Meperidine ESP block (2 arms). Primary endpoints: Intraoperative hypnotic consumption and Postoperative pain. Started Sep 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210415050983N5.